# Pharmacokinetic Study of Therapeutic Plasma Exchange

> **NCT07756242** · — · WITHDRAWN · sponsor: **University of Chicago**

## Conditions studied

- Immune-related Adverse Event

## Interventions

- **DEVICE:** Spectra Optia Apheresis System

## Key facts

- **NCT ID:** NCT07756242
- **Lead sponsor:** University of Chicago
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** WITHDRAWN
- **Start date:** 2026-11
- **Primary completion:** 2027-11
- **Final completion:** 2028-02
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** IRB Withdrew Study Due to Study Design Change
- **Last updated:** 2026-09-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07756242

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07756242, "Pharmacokinetic Study of Therapeutic Plasma Exchange". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07756242. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*